Circadian Functioning and Quality of Life in Substance Use Disorder Patients With and Without Comorbid Major Depressive Disorder

Abstract

Aim: Although a relationship between circadian disruption and development of several psychiatric disorders, such as major depressive disorder (MDD) and substance use disorder (SUD), has been observed, knowledge on this area is scarce yet. Therefore, this study aims to analyze the circadian functioning and quality of life (QOL) in SUD patients with and without comorbid MDD, two highly prevalent clinical entities with difficult therapeutic management.Methods: One hundred sixty-three male patients under treatment, 81 with SUD and 82 with SUD comorbid major depressive disorder (SUD + MDD), were evaluated. For the circadian functioning assessment, we calculated Social Jet Lag (SJL) and used the reduced Morningness–Eveningness Questionnaire (rMEQ) and the Pittsburgh Sleep Quality Index (PSQI). QOL was measured using the shortened version of the World Health Organization's Quality of Life Questionnaire (WHOQOL-BREF). We collected sociodemographic and clinical variables to evaluate their possible influence on the circadian functioning. Intergroup differences among the variables were examined by different analyses of covariance (ANCOVA and MANCOVA). The possible relationships of quantitative clinical variables with rMEQ, PSQI, and WHOQOL-BREF were explored using bivariate correlation analysis.Results: Lower SJL appears in the SUD + MDD group compared with SUD. The intermediate-type was more prevalent in the SUD group, while a higher percentage of morning-type patients was found in the SUD + MDD. Sleep quality (including latency and daytime dysfunction) was worse for SUD + MDD patients than for SUD even after controlling age and age of SUD onset variables. Last, QOL was poorer in patients with SUD + MDD and, for them, psychological health had a negative relationship with SJL and severity of depression.Conclusions: Our data support and extend previous findings indicating that SUD + MDD is associated with worse clinical characteristics, more sleep problems, and poorer QOL than SUD patients. These results underline the importance of a precise assessment of these measurements in future studies conducted in SUD patients with/without MDD comorbidity that could be considered from a therapeutic point of view.

Illegal drug use is associated with poorer life satisfaction and self-rated health (SRH) in young people

“…Future studies should investigate the various effects that different drugs may have on life satisfaction and SHR. Finally, illegal drug use is typically accompanied by psychiatric comorbidities and substance use disorders [e.g., ( 30 , 31 )]. However, they were not controlled in the model.…”

Effects of astaxanthin on depressive and sleep symptoms: A narrative mini-review

“…Iman Hashemzadeh et al conducted a survey that supports this view. They found that patients with comorbid substance use disorder (SUD) and major depressive disorder (MDD) experienced more early awakening, poorer sleep quality, and worse quality of life compared to patients with SUD alone [ 38 ]. A recent study has suggested that REM sleep plays a role in preventing emotional overreaction through somatodendritic decoupling, which can help dissolve negative emotions such as fear and stress [ 39 ].…”

The Influence of Artificial Light at Night on Asthma and Allergy, Mental Health, and Cancer Outcomes: A Systematic Scoping Review Protocol

“…Circadian function has been implicated in psychiatric and neurodegenerative diseases through a number of potential mechanisms [ 34 , 35 , 36 , 37 ]. Mental illnesses can be understandably complex, however, there is growing evidence of associations between these conditions and circadian dysfunction as well [ 38 , 39 , 40 ], which could possibly be mediated by altered sleep behaviour [ 38 ]. Additionally, disruption of circadian function through light exposure has long been considered in seasonal behavioural disorders [ 41 ].…”